Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/12/2025

Contraception Using Intrauterine Devices

Definition and Classification

  • The Centers for Disease Control and Prevention (CDC) uses "IUD" to classify both the levonorgestrel-releasing device (LNG-IUD) and the copper-bearing device (Cu-IUD) 1, 2, 3
  • IUD (Intrauterine Device) is the general term that includes all devices placed in the uterus for contraception, regardless of whether they release hormones 1, 2, 3

Clinical Implications

  • Both devices are highly effective contraceptives with failure rates less than 1% per year 4
  • Neither device protects against sexually transmitted infections or HIV 1, 5
  • Both are appropriate for nulliparous women, adolescents, and women in various medical conditions 4
  • Both can be inserted immediately postpartum or post-abortion 1, 6

Device Characteristics

  • The LNG-IUS provides therapeutic benefits for menorrhagia, dysmenorrhea, endometriosis, and adenomyosis 7
  • IUDs and subdermal implants are classified as progestin-only contraceptives by the CDC 4

REFERENCES

4

Progestin-Only Contraceptives [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Contraindications for the Use of Copper Intrauterine Devices [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

7

Contraceptive Efficacy and Therapeutic Benefits of Levonorgestrel-Releasing Intrauterine System [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025